Development of a Pharmaceutical Care Service Model for Patients with Diabetes in Ambulatory Care Settings.
10.24304/kjcp.2017.27.1.1
- Author:
Jeong Hyun YOON
1
Author Information
1. College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea. jyoon@pusan.ac.kr
- Publication Type:Review
- Keywords:
Pharmaceutical care;
diabetes;
service;
ambulatory;
team-based
- MeSH:
Ambulatory Care*;
Delivery of Health Care;
Drug Therapy;
Humans;
Mortality;
Pharmaceutical Services*;
Pharmacists;
Prevalence;
Quality of Life
- From:Korean Journal of Clinical Pharmacy
2017;27(1):1-8
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The prevalence of diabetes and its related morbidity and mortality are being increased. Despite the advancement of evidence-based pharmacotherapy in the management of diabetes, many patients in our country do not achieve satisfied therapeutic outcomes. Pharmaceutical care service can be defined as a patient-centered clinical service provided by pharmacists to improve therapeutic outcomes and quality of life of patients, by identifying, and preventing or resolving drug-related problems (DRPs). Pharmaceutical care service is interdisciplinary team-based practice, and is provided through collaborative practice agreement (CPA) between one or more physicians and pharmacists. This article describes a model of pharmaceutical care service which can be adopted in our country for patients with diabetes in the ambulatory care settings. With the successful implementation of this service, clinical, economic, and humanistic outcomes of patients will be improved. Therefore, by actively implementing pharmaceutical care service, pharmacist should contribute to the promotion of patients' health and to the advancement of health care delivery system.
